Coronary Artery Disease Clinical Trials in Indianapolis, Indiana

6 studies are recruiting for coronary artery disease in Indianapolis, Indiana right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Product Surveillance Registry

   The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

   Stage

   Not phased

   Ages

   Any age

   Site

   Research site, Indianapolis, Indiana

   Locations

   401 in total

   Run by

   Medtronic

   See if you can join NCT01524276 on ClinicalTrials.gov

2. Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

   Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…

   Stage

   Not phased

   Ages

   Any age

   Site

   St. Vincent Heart Center, Indianapolis, Indiana

   Locations

   48 in total

   Run by

   Minneapolis Heart Institute Foundation

   See if you can join NCT02061436 on ClinicalTrials.gov

3. Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

   Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant

   Stage

   Not phased

   Ages

   18 to 99

   Site

   Indiana University, Indianapolis, Indiana

   Run by

   Indiana University

   See if you can join NCT05611307 on ClinicalTrials.gov

4. Virtue® SAB in the Treatment of Coronary ISR Trial

   A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).

   Stage

   Not phased

   Ages

   18 and older

   Site

   Ascension St. Vincent, Indianapolis, Indiana

   Locations

   15 in total

   Run by

   Orchestra BioMed, Inc

   See if you can join NCT07045194 on ClinicalTrials.gov

5. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

   The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Indiana University, Indianapolis, Indiana

   Locations

   146 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT04124120 on ClinicalTrials.gov

6. PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

   This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Ascension St. Vincent, Indianapolis, Indiana

   Locations

   18 in total

   Run by

   Kardion Inc

   See if you can join NCT06445608 on ClinicalTrials.gov